Search results for: treatment
CMT2A in the Lab: A Closer Look at How Treatments Are Tested
What if you could watch CMT2A unfold inside a neuron? CMTA’s new partnership just made it possible, and the early findings are changing the game.
How the CMT2C Community Is Driving the Path to Treatment
How is the CMT2C community helping move research forward? A CMTA-hosted focus group on how patient voices are shaping the path to a treatment.
CMTA Invests $281,339 to Advance Treatments for CMT1A
The newly funded study will test whether molecules originally in development as cancer therapeutics can also be used to lower PMP22 and improve nerve health in a model of CMT1A.
FDA Meeting Could Pave the Way for First CMT Treatment
Applied Therapeutics secures FDA meeting this fall on its plan to submit govorestat for CMT-SORD. And what’s this about a free SORD test?
Particles on a Mission: Can Nanoparticles Solve One of CMT’s Largest Hurdles?
Can nanoparticles solve one of CMT’s largest hurdles? A team in Cyprus is testing nanoparticle “mail carriers” designed to deliver genetic therapies directly into Schwann cells.
What Can Long-Read Sequencing Reveal About CMT?
What happened when CMTA-supported scientists at University College London applied long-read sequencing to CMT cases that had no genetic confirmation for years?
UVA Health’s Francesco Michelassi, MD, PhD, Joins the CMTA Centers of Excellence Network
Virginia-based CMT expert joins CMTA’s Centers of Excellence network. Big things are happening in Charlottesville for the CMT community.
Giving Toesday
Giving Tuesday is a global day of generosity that inspires people everywhere to give back...
Novartis 1A – Patient Lived Experience Project
About this study Share your experiences with Charcot-Marie-Tooth disease type 1A (CMT1A) in an online...
Every Story Moves Us Closer
Every Story Moves Us Closer Each step forward in CMT research is powered by stories...